Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.41 USD | -0.26% | +0.88% | -.--% |
05-16 | ArriVent BioPharma, Inc. Appoints John Hohneker as Board of Directors | CI |
05-08 | ArriVent BioPharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bullish | Neutral | Neutral |
Resistance | 20.15 | 22.75 | 22.47 |
Spread/Res. | -3.67% | -14.68% | -13.62% |
Spread/Supp. | +7.89% | +26.86% | +25.71% |
Support | 17.99 | 15.30 | 15.44 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- AVBP Stock
- Charts ArriVent BioPharma, Inc.